06:37 AM EDT, 04/23/2024 (MT Newswires) -- Sophia Genetics ( SOPH ) said Tuesday that Nigeria-based Syndicate Bio has signed on to implement the medicine software company's MSK-Access laboratory platform, giving patients access to cloud-based genomic profiling and liquid biopsy testing.
The move aims at "accelerating the cancer treatment and research landscape across Africa, beginning in Nigeria," Syndicate Bio's founder, Abasi Ene-Obong, said in a statement.
Financial details were not disclosed.